triple glp 1 gip glucagon receptor agonist Discovery of a potent and long-acting Xenopus GLP-1-based GLP-1/glucagon/Y2 The dual glucose-dependent insulinotropic polypeptide

The matrine derivate MASM inhibits astrocyte reactivity and alleviates experimental autoimmune encephalomyelitis in mice

While the ongoing SURPASS clinical trial aims to elucidate the mechanistic underpinnings of the drug and the best dosages for treating patients of varying BMIs, its benefits cannot be understated

Tirzepatide is an FDA-approved dual GIP/GLP-1 receptor agonist that reduces appetite and improves glucose control, while creatine is a widely used supplement that enhances muscle performance and mass

Discover the difference for a healthier you

Among ten supplements recently selected for testing, ConsumerLab